Innate Pharma S.A.
IPH.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€21 | -€25 | -€25 | -€9 |
| Dep. & Amort. | €1 | €1 | €1 | €1 |
| Deferred Tax | €0 | €0 | €0 | €0 |
| Stock-Based Comp. | €2 | €0 | €2 | €3 |
| Change in WC | -€10 | €13 | €31 | -€14 |
| Other Non-Cash | -€2 | €1 | -€6 | -€3 |
| Operating Cash Flow | -€31 | -€10 | €3 | -€21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€0 | -€0 | -€0 | -€2 |
| Net Acquisitions | €0 | €0 | €0 | €0 |
| Inv. Purchases | €0 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €0 | €8 | €1 | €23 |
| Other Inv. Act. | €7 | €0 | €0 | €0 |
| Investing Cash Flow | €7 | €8 | €1 | €21 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€4 | -€5 | -€4 | -€1 |
| Stock Issued | €15 | €3 | €0 | €0 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €0 | €0 | -€0 | €0 |
| Financing Cash Flow | €10 | -€2 | -€4 | -€1 |
| Forex Effect | €1 | -€0 | -€0 | €0 |
| Net Chg. in Cash | -€13 | -€4 | -€1 | -€1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €66 | €70 | €71 | €71 |
| End Cash | €54 | €66 | €70 | €71 |
| Free Cash Flow | -€31 | -€10 | €3 | -€21 |